Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm.

ABSTRACT:

SUBMITTER: Palmieri R 

PROVIDER: S-EPMC7384960 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature